New polypeptide, DNA encoding the polypeptide, recombinant vector bearing the DNA and recombinant virus utilizing the recombinant vector as well as use thereof

A polypeptide showing an antigenicity to Mycoplasma qallisepticum , a fused polypeptide of said polypeptide ligated at the N terminus thereof with a signal membrane anchor of type II external membrane polypeptide of virus that infects to fowl, or a polypeptide showing an antigenicity which is substa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	OHSAWA, IKUROH, SAITO, SHUJI, SAEKI, SAKIKO, OHKAWA, SETSUKO, FUNATO, HIRONO, IRITANI, YOSHIKAZU, TAKAHASHI, KIYOHITO, AOYAMA, SHIGEMI
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A polypeptide showing an antigenicity to Mycoplasma qallisepticum , a fused polypeptide of said polypeptide ligated at the N terminus thereof with a signal membrane anchor of type II external membrane polypeptide of virus that infects to fowl, or a polypeptide showing an antigenicity which is substantially pure and reactive with Mycoplasma -immunized sera or Mycoplasm infected sera, and having an amino acid sequence of about 32 kilodaltons, about 40 kilodaltons or about 70 kilodaltons, expression thereof or a modified polypeptide to such an extent that shows an imnunogenicity equivalent to that of said polypeptide using a recombinant virus, and use c the recombinant virus as a live vaccine.